IT IS A CENTURY-old way of treating viral diseases. In Covid-19, though, the use of antibody-rich convalescent plasma (CP), has been controversial given the lack of strong evidence.
“Ours is the world’s largest trial [of its kind] on plasma therapy,” Dr Balram Bhargava, director-general, Indian Council of Medical Research (ICMR), said in response to THE WEEK’s query on the plasma therapy (PLACID) trial. “The trial has been conducted on 464 patients, where 235 patients with moderate Covid-19 disease were given plasma, the rest were given best standard care. This was done in 39 hospitals across India, and we looked at whether it led to severe disease or death over 28 days.” The results of the open label, randomised controlled trial (RCT) published as a pre-print (peer-review pending) suggest that there was no difference in 28-day mortality or progression to severe disease among those studied.
“The study also indicates that the key point here is the high titre [levels] of neutralising antibodies for it to work, if at all,” said professor Sunit K. Singh, head, molecular biology, Banaras Hindu University. “Besides, we have to be sure that the donor does not have any viral RNA in their blood.”
Bu hikaye THE WEEK dergisinin September 20, 2020 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye THE WEEK dergisinin September 20, 2020 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
What Will It Take To Clean Up Delhi Air?
IT IS ASKED, year after year, why Delhi’s air remains unbreathable despite several interventions to reduce pollution.
Trump and the crisis of liberalism
Although Donald Trump's election to a non-consecutive second term to the US presidency is not unprecedented—Grover Cleveland had done it in 1893—it is nevertheless a watershed moment.
Men eye the woman's purse
A couple of months ago, I chanced upon a young 20-something man at my gym walking out with a women’s sling bag.
When trees hold hands
A filmmaker explores the human-nature connect through the living root bridges
Ms Gee & Gen Z
The vibrant Anuja Chauhan and her daughter Nayantara on the generational gap in romance writing
Vikram Seth-a suitable man
Our golden boy of literature was the star attraction at the recent Shillong Literary Festival in mysterious Meghalaya.
Superman bites the dust
When my granddaughter Kim was about three, I often took her to play in a nearby park.
OLD MAN AND THE SEA
Meet G. Govinda Menon, the 102-year-old engineer who had a key role in surveying the Vizhinjam coast in the 1940s, assessing its potential for an international port
Managing volatility: smarter equity choices in uncertain markets
THE INDIAN STOCK MARKET has delivered a strong 11 per cent CAGR over the past decade, with positive returns for eight straight years.
Investing in actively managed low-volatility portfolios keeps risks at bay
AFTER A ROARING bull market over the past year, equity markets in the recent months have gone into a correction mode as FIIs go on a selling spree. Volatility has risen and investment returns are hurt.
